News

For the quarter ended September 2025, Nasdaq (NDAQ) reported revenue of $1.32 billion, up 14.8% over the same period last year. EPS came in at $0.88, compared to $0.74 in the year-ago quarter.

The

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Philip Morris (PM) reported $10.85 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 9.4%. EPS of $2.24 for the same period compares to $1.91 a year

General Motors (GM) reported $48.59 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.3%. EPS of $2.80 for the same period compares to $2.96 a year

3M (MMM) reported $6.32 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 0.4%. EPS of $2.19 for the same period compares to $1.98 a year ago.

The

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Genuine Parts (GPC) reported $6.26 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 4.9%. EPS of $1.98 for the same period compares to $1.88 a year

RTX (RTX) reported $22.48 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 11.9%. EPS of $1.70 for the same period compares to $1.45 a year ago.

The

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

For the quarter ended September 2025, PulteGroup (PHM) reported revenue of $4.4 billion, down 1.6% over the same period last year. EPS came in at $2.96, compared to $3.35 in the year-ago quarter.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Northrop Grumman (NOC) reported $10.42 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 4.3%. EPS of $7.67 for the same period compares to $7.00 a

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

For the quarter ended September 2025, Pentair plc (PNR) reported revenue of $1.02 billion, up 2.9% over the same period last year. EPS came in at $1.24, compared to $1.09 in the year-ago quarter.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Valmont Industries (VMI) reported $1.05 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 2.5%. EPS of $4.98 for the same period compares to $4.11 a

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Elevance Health (ELV) reported $50.09 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 12%. EPS of $6.03 for the same period compares to $8.37 a

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Peoples Bancorp (PEBO) reported $115.18 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 1.3%. EPS of $0.90 for the same period compares to $0.89 a

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

One of our most popular

Novo Nordisk NVO received FDA approval for a regulatory application seeking the label expansion of its oral GLP-1 drug, Rybelsus (semaglutide), to include cardiovascular (CV) risk reduction in

Quest Diagnostics Inc.’s DGX third-quarter 2025 adjusted earnings per share (EPS) of $2.60 beat the Zacks Consensus Estimate by 3.59%. The metric also exceeded the year-ago adjusted figure by 13%.